EPO and anemia: Practical clinical use of EPO may occur for a limited period, especially in patients with worsening symptoms of degenerative cervical myelopathy who have higher systemic risks such as severe anemia, older age, and diabetes mellitus, and those who live far from a hospital that performs spinal surgery.